Conference Reports for NATAP

10th International Congress on Drug Therapy in HIV Infection Glasgow November 7-11, 2010 Back

Switching to Atripla (EFV/FTC/TDF) from Kivexa (ABC/3TC) Plus EFV Leads to Improved Perceptions of Treatment: Results from the ROCKET 1 Study       Reported by Jules Levin Glasgow 2010 Nov 7-11   V Cooper,1 R Horne,1 and J Ewan2 1 The School of Pharmacy, University of London, London, UK; 2Gilead Sciences Ltd., Cambridge, UK